Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Thalassemia and autoimmune diseases: absence of evidence or evidence of absence?.Blood Rev. 2022; 52: 100874
- Autoimmune hemolytic anemia as a complication of congenital anemias. A case series and review of the literature.J Clin Med. 2021; 10: 3439
- Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy.Am J Hematol. 2020; 95: 456-464
- Survival and complications in thalassemia.Ann N Y Acad Sci. 2005; 1054: 40-47
- Electrocardiographic presentation, cardiac arrhythmias, and their management in β-thalassemia major patients.Ann Noninvasive Electrocardiol. 2016; 21: 335-342
- Electrocardiographic consequences of cardiac iron overload in thalassemia major.Am J Hematol. 2012; 87: 139-144
- Atrial fibrillation in beta-thalassemia major patients: diagnosis, management and therapeutic options.Hemoglobin. 2018; 42: 189-193
- Vitamin D and bone health status in beta thalassemia patients-systematic review.Osteoporos Int. 2021; 32: 1031-1040
- Arrhythmias and sudden cardiac death in beta-thalassemia major patients: noninvasive diagnostic tools and early markers.Cardiol Res Pract. 2019; 2019: 9319832
- Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.Intern Emerg Med. 2017; 12: 799-809
- On T2∗ magnetic resonance and cardiac iron.Circulation. 2011; 123: 1519-1528
- Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association.Circulation. 2013; 128: 281-308
- Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.HemaSphere. 2021; 6: e732
- Cholelithiasis in thalassemia major patients: a report from the south-east of iran.Int J Hematol Oncol Stem Cell Res. 2018; 12: 117-122
- Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.Iran Red Crescent Med J. 2014; 16: e18712
- Clinical pathology aspect on diagnosis cholelithiasis in beta-Thalassemia patient: a case report.Ann Med Surg (Lond). 2022; 81: 104454
- Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran.Med Sci Monit. 2009; 15: CR398-CR402
- Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia.Br J Haematol. 2001; 115: 926-928
- Thalassemia minor, the Gilbert mutation, and the risk of gallstones.Haematologica. 2003; 88: 1106-1109
- Association of beta-thalassaemia and hypogonadotropic hypogonadism.Case Rep Obstet Gynecol. 2022; 2022: 4655249
- Growth and factors affecting it in thalassemia major.Hemoglobin. 2009; 33: S116-S126
- Growth and endocrine function in tunisian thalassemia major patients.Mediterr J Hematol Infect Dis. 2018; 10: e2018031
- The multifactorial origin of growth failure in thalassaemia.Pediatr Endocrinol Rev. 2011; 8: 271-277
- Growth hormone deficiency in adults with thalassemia: an overview and the I-CET recommendations.Georgian Med News. 2013; : 79-88
- Growth hormone–insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major.Indian J Endocrinol Metab. 2014; 18: 32
- The prevalence of hypothyroidism among patients with β-thalassemia: a systematic review and meta-analysis of cross-sectional studies.Hemoglobin. 2021; 45: 275-286
- Some aspects of thyroid dysfunction in thalassemia major patients with severe iron overload.Paediatr Indonesiana. 2011; 51: 66-72
- The ICET-A recommendations for the diagnosis and management of disturbances of glucose homeostasis in thalassemia major patients.Mediterr J Hematol Infect Dis. 2016; 8e2016058
- Hypothyroidism and hypoparathyroidism in thalassemia major patients: a study in sistan and baluchestan province, iran.Int J Endocrinol Metab. 2018; 16: e13228
- Unique classification of parathyroid dysfunction in patients with transfusion dependent thalassemia major using Nomogram-A cross sectional study.Ann Med Surg. 2019; 45: 22-26
- An ICET-A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report.Acta Bio Med Atenei Parmensis. 2017; 88: 435
- Hypoparathyroidism in adult patients with Beta-thalassemia major.Sultan Qaboos Univ Med J. 2007; 7: 215-218
- Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.Br J Haematol. 2009; 146: 546-556
- Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.BMC Nephrol. 2020; 21: 482
- The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran.Mediterr J Hematol Infect Dis. 2015; 7: e2015005
- A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing.J Pediatr Hematol Oncol. 2015; 37: 54
- New insights and methods in the approach to thalassemia major: the lesson from the case of adrenal insufficiency.Front Mol Biosci. 2019; 6: 162
- Adrenal insufficiency: an emerging challenge in thalassemia?.Am J Hematol. 2017; 92: E119-E121
Guzelbey T., Gurses B., Ozturk E., et al., Evaluation of iron deposition in the adrenal glands of β thalassemia major patients using 3-tesla MRI, Iranian J Radiol, 13 (3), 2016, e36375.
- The role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.Blood Rev. 2012; 26: S12-S15
- Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia.Eur Spine J. 2010; 19: 871-878
- Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.Ann Hematol. 2002; 81: 478-482
- Non-transfusion-dependent thalassemias.Haematologica. 2013; 98: 833-844
- Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.Blood. 2010; 115: 1886-1892
- Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with beta thalassemia intermedia.Blood Cells Mol Dis. 2011; 47: 232-234
- Serum ferritin levels and morbidity in β-thalassemia intermedia: a 10-year cohort study.Blood. 2012; 120: 1021
- Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with beta-thalassemia intermedia.Blood Cells Mol Dis. 2013; 51: 35-38
- Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.Haematologica. 2011; 96: 1605
- Healing of leg ulcers with hydroxyurea in thalassaemia intermedia patients with associated endocrine complications.Pediatr Endocrinol Rev. 2004; 2: 319-322
- Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease.Acta Haematol. 1991; 86: 46-48
- Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.J Clin Pharmacol. 1985; 25: 8-26
- A double-blind placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients.Southeast Asian J Trop Med Public Health. 1997; 28: 167-171
- Treatment of leg ulcers with platelet-derived wound healing factor (PDWHFS) in a patient with beta thalassaemia intermedia.Br J Haematol. 2001; 112: 527-529
- Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy.Isr Med Assoc J. 2011; 13: 316-318
- Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.Br J Haematol. 2009; 146: 569-572
- Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.Hepatobiliary Pancreat Dis Int. 2016; 15: 461-479
- High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions.Vox Sang. 2003; 84: 292-299
- Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with beta-Thalassemia Major.J Clin Exp Hepatol. 2018; 8: 3-6
- Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.Aliment Pharmacol Ther. 2017; 46: 424-431
- Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study.Hepatology. 2017; 66: 736-745
- Sofosbuvir/velpatasvir for chronic hepatitis C infection in patients with transfusion-dependent thalassemia.Am J Hematol. 2019; 94: E43-E45
- Hepatocellular carcinoma in β-thalassemia patients: review of the literature with molecular insight into liver carcinogenesis.Int J Mol Sci. 2018; 19: 4070
- Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic.Am J Hematol. 2005; 78: 158-159
- A prospective study of hepatocellular carcinoma incidence in thalassemia.Hemoglobin. 2006; 30: 119-124
- Hepatocellular carcinoma in thalassemia: a critical review.World J Hepatol. 2010; 2: 171-174
- Current management strategy of hepatocellular carcinoma.World J Gastroenterol. 2009; 15: 3210-3216
- Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?.Br J Haematol. 2015; 168: 304-305
- Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.Pediatr Blood Cancer. 2009; 53: 1064-1067
- Thalassaemia and risk of cancer: a population-based cohort study.J Epidemiol Community Health. 2015; 69: 1066-1070
- Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.Haematologica. 2004; 89: 1187-1193
- Improved survival of thalassaemia major in the UK and relation to T2∗ cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2008; 10: 42
- National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.Ann Hematol. 2019; 98: 55-66
- Thalassemia and malignancy: An emerging concern?.Blood Rev. 2019; 37: 100585
- New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.Br J Haematol. 2004; 127: 127-139
- Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.Br J Haematol. 2003; 123: 730-737
- Effect of cyclic pamidronate administration on osteoporosis in children with beta-thalassemia major: a single-center study.Clin Exp Pediatr. 2022; 65: 405-409
- Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.Haematologica. 2006; 91: 1193-1202
- Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major.Indian J Hematol Blood Transfus. 2018; 34: 648-652
- Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis.Medicine (Baltimore). 2020; 99: e23637
- Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis.Indian J Endocrinol Metab. 2014; 18: 546-551
- Efficacy and safety of teriparatide in beta-thalassemia major associated osteoporosis: a real-life experience.Calcif Tissue Int. 2022; 111: 56-65
- Impact of bone disease and pain in thalassemia.Hematol Am Soc Hematol Educ Program. 2017; 2017: 272-277
- Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.Circulation. 2014; 129: 338-345
- Cardiopulmonary assessment in beta-thalassemia major.Chest. 1990; 98: 1138-1142
- Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.Chest. 1995; 107: 50-53
- Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Chest. 2010; 137: 30S-38S
- Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked.Circulation. 2011; 123: 1227-1232
- Pulmonary hypertension in thalassemia.Ann N Y Acad Sci. 2010; 1202: 205-213
- Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension.Blood. 2002; 100: 1516-1517
- Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.Haematologica. 2005; 90: 452-458
- Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up.Haematologica. 2014; 99: e17-e18
- Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.Blood. 2012; 120: 1531-1532
- Pulmonary arterial hypertension in a patient with beta-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Pulm Circ. 2014; 4: 520-526
- The improvement of pulmonary artery pressure after bosentan therapy in patients with beta-thalassemia and Doppler-defined pulmonary arterial hypertension.Int Med Case Rep J. 2019; 12: 1-7
- Renal dysfunction in patients with thalassaemia.Br J Haematol. 2011; 153: 111-117
- Mechanisms of renal disease in beta-thalassemia.J Am Soc Nephrol. 2012; 23: 1299-1302
- Renal complications in transfusion-dependent beta thalassaemia.Blood Rev. 2010; 24: 239-244
- Renal aspects of thalassaemia a changing paradigm.Eur J Haematol. 2012; 89: 187-197
- Glomerular hyperfiltration and proteinuria in transfusion-independent patients with beta-thalassemia intermedia.Nephron Clin Pract. 2012; 121: c136-c143
- End stage renal disease in six patients with beta-thalassemia intermedia.Blood Cells Mol Dis. 2013; 51: 146-148
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
